Calcium Carbonate Nanoparticles Stop Cancer by Neutralizing the Tumor Microenvironment
By LabMedica International staff writers Posted on 17 Feb 2016 |
Image: Space-filling model of part of the crystal structure of calcium carbonate, CaCO3 (Photo courtesy of Wikimedia Commons).
Tumor growth was halted in a mouse cancer model by the injection of novel calcium carbonate nanoparticles that neutralized the pH of the tumor microenvironment.
The acidic extracellular environment of tumors increases their aggressiveness and potential to metastasize, but few methods exist to selectively modulate the extracellular pH of the tumor environment. Transient flushing of biological systems with alkaline fluids or proton pump inhibitors is impractical and nonselective.
Investigators at Washington University (St. Louis, MO, USA) tried a new approach to modulate the pH of the tumor microenvironment. They used two processes, polyethyleneglycol-based diffusion and ethanol-assisted diffusion, to prepare calcium carbonate nanoparticles ranging in size from 20 to 300 microns. The nanoparticles were suspended in an albumin-based solvent that prevented aggregation and allowed them to be injected intravenously into an animal.
The investigators reported in the December 25, 2015, online edition of the journal Nanoscale that by using a mouse cancer model they were able to demonstrate that the selective accumulation of nano-calcium carbonate in tumors increased tumor pH over time, eventually reaching pH 7.4. Daily injections of calcium carbonate nanoparticles halted tumor growth in the mouse fibrosarcoma model, but stopping the injections allowed tumor growth to resume.
"Cancer kills because of metastasis," said Avik Som, a medical and doctoral student in biomedical engineering at Washington University. "The pH of a tumor has been heavily correlated with metastasis. For a cancer cell to get out of the extracellular matrix, or the cells around it, one of the methods it uses is a decreased pH. Calcium and carbonate are both found heavily in the body, and they are generally non-toxic. When calcium carbonate dissolves, the carbonate becomes carbon dioxide and is released through the lungs, and calcium is often incorporated into the bones."
Related Links:
Washington University
The acidic extracellular environment of tumors increases their aggressiveness and potential to metastasize, but few methods exist to selectively modulate the extracellular pH of the tumor environment. Transient flushing of biological systems with alkaline fluids or proton pump inhibitors is impractical and nonselective.
Investigators at Washington University (St. Louis, MO, USA) tried a new approach to modulate the pH of the tumor microenvironment. They used two processes, polyethyleneglycol-based diffusion and ethanol-assisted diffusion, to prepare calcium carbonate nanoparticles ranging in size from 20 to 300 microns. The nanoparticles were suspended in an albumin-based solvent that prevented aggregation and allowed them to be injected intravenously into an animal.
The investigators reported in the December 25, 2015, online edition of the journal Nanoscale that by using a mouse cancer model they were able to demonstrate that the selective accumulation of nano-calcium carbonate in tumors increased tumor pH over time, eventually reaching pH 7.4. Daily injections of calcium carbonate nanoparticles halted tumor growth in the mouse fibrosarcoma model, but stopping the injections allowed tumor growth to resume.
"Cancer kills because of metastasis," said Avik Som, a medical and doctoral student in biomedical engineering at Washington University. "The pH of a tumor has been heavily correlated with metastasis. For a cancer cell to get out of the extracellular matrix, or the cells around it, one of the methods it uses is a decreased pH. Calcium and carbonate are both found heavily in the body, and they are generally non-toxic. When calcium carbonate dissolves, the carbonate becomes carbon dioxide and is released through the lungs, and calcium is often incorporated into the bones."
Related Links:
Washington University
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples